vs
Acadia Healthcare Company, Inc.（ACHC）与泰瑞达（TER）财务数据对比。点击上方公司名可切换其他公司
泰瑞达的季度营收约是Acadia Healthcare Company, Inc.的1.3倍（$1.1B vs $821.5M），泰瑞达净利率更高（23.7% vs -143.3%，领先167.1%），泰瑞达同比增速更快（43.9% vs 6.1%），泰瑞达自由现金流更多（$218.8M vs $-179.5M），过去两年泰瑞达的营收复合增速更高（34.4% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
泰瑞达是总部位于美国马萨诸塞州北雷丁的自动测试设备（ATE）设计及制造企业，在全球半导体测试领域拥有深厚技术积累，服务的知名客户涵盖三星、高通、英特尔、亚德诺、德州仪器、IBM等行业头部企业。
ACHC vs TER — 直观对比
营收规模更大
TER
是对方的1.3倍
$821.5M
营收增速更快
TER
高出37.8%
6.1%
净利率更高
TER
高出167.1%
-143.3%
自由现金流更多
TER
多$398.2M
$-179.5M
两年增速更快
TER
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $1.1B |
| 净利润 | $-1.2B | $257.2M |
| 毛利率 | — | 57.2% |
| 营业利润率 | -142.4% | 27.1% |
| 净利率 | -143.3% | 23.7% |
| 营收同比 | 6.1% | 43.9% |
| 净利润同比 | -3710.4% | 75.9% |
| 每股收益（稀释后） | $-12.98 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCTER
| Q4 25 | $821.5M | $1.1B | ||
| Q3 25 | $851.6M | $769.2M | ||
| Q2 25 | $869.2M | $651.8M | ||
| Q1 25 | $770.5M | $685.7M | ||
| Q4 24 | $774.2M | $752.9M | ||
| Q3 24 | $815.6M | $737.3M | ||
| Q2 24 | $796.0M | $729.9M | ||
| Q1 24 | $768.1M | $599.8M |
净利润ACHCTER
| Q4 25 | $-1.2B | $257.2M | ||
| Q3 25 | $36.2M | $119.6M | ||
| Q2 25 | $30.1M | $78.4M | ||
| Q1 25 | $8.4M | $98.9M | ||
| Q4 24 | $32.6M | $146.3M | ||
| Q3 24 | $68.1M | $145.6M | ||
| Q2 24 | $78.5M | $186.3M | ||
| Q1 24 | $76.4M | $64.2M |
毛利率ACHCTER
| Q4 25 | — | 57.2% | ||
| Q3 25 | — | 58.4% | ||
| Q2 25 | — | 57.2% | ||
| Q1 25 | — | 60.6% | ||
| Q4 24 | — | 59.4% | ||
| Q3 24 | — | 59.2% | ||
| Q2 24 | — | 58.3% | ||
| Q1 24 | — | 56.6% |
营业利润率ACHCTER
| Q4 25 | -142.4% | 27.1% | ||
| Q3 25 | 4.7% | 18.9% | ||
| Q2 25 | 5.8% | 13.9% | ||
| Q1 25 | 1.7% | 17.6% | ||
| Q4 24 | 4.9% | 20.4% | ||
| Q3 24 | 12.1% | 20.6% | ||
| Q2 24 | 13.4% | 28.8% | ||
| Q1 24 | 12.9% | 13.0% |
净利率ACHCTER
| Q4 25 | -143.3% | 23.7% | ||
| Q3 25 | 4.3% | 15.5% | ||
| Q2 25 | 3.5% | 12.0% | ||
| Q1 25 | 1.1% | 14.4% | ||
| Q4 24 | 4.2% | 19.4% | ||
| Q3 24 | 8.4% | 19.8% | ||
| Q2 24 | 9.9% | 25.5% | ||
| Q1 24 | 9.9% | 10.7% |
每股收益（稀释后）ACHCTER
| Q4 25 | $-12.98 | $1.62 | ||
| Q3 25 | $0.40 | $0.75 | ||
| Q2 25 | $0.33 | $0.49 | ||
| Q1 25 | $0.09 | $0.61 | ||
| Q4 24 | $0.36 | $0.89 | ||
| Q3 24 | $0.74 | $0.89 | ||
| Q2 24 | $0.85 | $1.14 | ||
| Q1 24 | $0.83 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $293.8M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | $2.8B |
| 总资产 | $5.5B | $4.2B |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCTER
| Q4 25 | $133.2M | $293.8M | ||
| Q3 25 | $118.7M | $272.7M | ||
| Q2 25 | $131.4M | $339.3M | ||
| Q1 25 | $91.2M | $475.6M | ||
| Q4 24 | $76.3M | $553.4M | ||
| Q3 24 | $82.1M | $510.0M | ||
| Q2 24 | $77.2M | $421.9M | ||
| Q1 24 | $77.3M | $707.4M |
总债务ACHCTER
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
股东权益ACHCTER
| Q4 25 | $1.9B | $2.8B | ||
| Q3 25 | $3.1B | $2.7B | ||
| Q2 25 | $3.1B | $2.8B | ||
| Q1 25 | $3.0B | $2.8B | ||
| Q4 24 | $3.1B | $2.8B | ||
| Q3 24 | $3.0B | $2.9B | ||
| Q2 24 | $3.0B | $2.7B | ||
| Q1 24 | $2.9B | $2.6B |
总资产ACHCTER
| Q4 25 | $5.5B | $4.2B | ||
| Q3 25 | $6.4B | $4.0B | ||
| Q2 25 | $6.3B | $3.8B | ||
| Q1 25 | $6.1B | $3.7B | ||
| Q4 24 | $6.0B | $3.7B | ||
| Q3 24 | $5.9B | $3.8B | ||
| Q2 24 | $5.7B | $3.6B | ||
| Q1 24 | $5.5B | $3.4B |
负债/权益比ACHCTER
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $281.6M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $218.8M |
| 自由现金流率自由现金流/营收 | -21.8% | 20.2% |
| 资本支出强度资本支出/营收 | 11.3% | 5.8% |
| 现金转化率经营现金流/净利润 | — | 1.09× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $450.4M |
8季度趋势，按日历期对齐
经营现金流ACHCTER
| Q4 25 | $-86.3M | $281.6M | ||
| Q3 25 | $73.2M | $49.0M | ||
| Q2 25 | $133.5M | $182.1M | ||
| Q1 25 | $11.5M | $161.6M | ||
| Q4 24 | $116.7M | $282.6M | ||
| Q3 24 | $163.1M | $166.3M | ||
| Q2 24 | $171.1M | $216.1M | ||
| Q1 24 | $-321.3M | $7.3M |
自由现金流ACHCTER
| Q4 25 | $-179.5M | $218.8M | ||
| Q3 25 | $-63.0M | $2.4M | ||
| Q2 25 | $-34.2M | $131.7M | ||
| Q1 25 | $-163.2M | $97.6M | ||
| Q4 24 | $-86.8M | $225.2M | ||
| Q3 24 | $-27.1M | $114.4M | ||
| Q2 24 | $16.9M | $171.2M | ||
| Q1 24 | $-463.7M | $-36.7M |
自由现金流率ACHCTER
| Q4 25 | -21.8% | 20.2% | ||
| Q3 25 | -7.4% | 0.3% | ||
| Q2 25 | -3.9% | 20.2% | ||
| Q1 25 | -21.2% | 14.2% | ||
| Q4 24 | -11.2% | 29.9% | ||
| Q3 24 | -3.3% | 15.5% | ||
| Q2 24 | 2.1% | 23.5% | ||
| Q1 24 | -60.4% | -6.1% |
资本支出强度ACHCTER
| Q4 25 | 11.3% | 5.8% | ||
| Q3 25 | 16.0% | 6.1% | ||
| Q2 25 | 19.3% | 7.7% | ||
| Q1 25 | 22.7% | 9.3% | ||
| Q4 24 | 26.3% | 7.6% | ||
| Q3 24 | 23.3% | 7.0% | ||
| Q2 24 | 19.4% | 6.1% | ||
| Q1 24 | 18.5% | 7.3% |
现金转化率ACHCTER
| Q4 25 | — | 1.09× | ||
| Q3 25 | 2.02× | 0.41× | ||
| Q2 25 | 4.43× | 2.32× | ||
| Q1 25 | 1.37× | 1.63× | ||
| Q4 24 | 3.58× | 1.93× | ||
| Q3 24 | 2.39× | 1.14× | ||
| Q2 24 | 2.18× | 1.16× | ||
| Q1 24 | -4.21× | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
TER
| Soc | $646.5M | 60% |
| Memory | $206.5M | 19% |
| Transferred At Point In Time | $90.0M | 8% |
| Universal Robots | $89.4M | 8% |
| IST | $30.5M | 3% |
| Transferred Over Time | $20.5M | 2% |
